CYQ
Cycliq Group Ltd
π¦πΊ ASX
ποΈ CONSUMER
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
-16.00%
Annual Growth
5 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
1
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Cycliq Group Ltd. engages in the manufacture of electronic safety accessories for cyclists. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2007-11-21. The company operates predominantly in the technology industry, manufacturing high-definition bike cameras and safety lights. The company has operations in Australia and China, with direct-to-consumer sales from its Website and Amazon, and access to more than 6,000 retail points of presence through a network of regional distributors and retail partners in the United States, United Kingdom, European Union (EU) and Asia-Pacific. The firm provides various accessories, including Duo Mount, Saddle Rail Mount, Fly6 - Rear Pannier Mount Pack, Fly12 - Handlebar Mount, Universal Adapter Pack, Cycliq Security Tag Holder, Microphone Filters and Fly6 Gen 3 Silicone Case. The company also offers lumiere unisex reflective jackets. Its subsidiaries include Cycliq Products Pty Ltd and Cycliq Research and Development (HK) Ltd.
π Performance
Price History
-99.92%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.00
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in CYQ
1
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in CYQ
N/A
CYQ investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100%
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
100%
35 - 90
π Legal gender of investors
Female
Male
100%
Pearlers who invest in CYQ also invest in...
ASIA.AX was created on 2018-09-18 by BetaShares. The fund's investment portfolio concentrates primarily on information technology equity. The investment objective of the BetaShares Asia Technology Tigers ETF is to provide an investment return that aims to track the performance of the Solactive Asia ex-Japan Technology & Internet Tigers Index (the Index), before taking into account fees and expenses.
π Performance (5Yr p.a)
8.24%
π Share price
$10.25 AUD
π¦πΊ EX AUSTRALIA
VEU.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard All-World ex-US Shares Index ETF seeks to track the return of the FTSE All-World ex US Index before taking into account fees, expenses and tax
π Performance (5Yr p.a)
3.74%
π Share price
$92.34 AUD
β³οΈ DIVERSIFIED
π GLOBAL
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
π Performance (5Yr p.a)
4.19%
π Share price
$137.97 AUD
πΈ FINANCIALS
β³οΈ DIVERSIFIED
π¦πΊ AUSTRALIA
VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
π Performance (5Yr p.a)
19.66%
π Share price
$470.94 AUD
π€ TECHNOLOGY
π HIGH PRICE GROWTH
β³οΈ DIVERSIFIED
πΊπΈ UNITED STATES
Metrics Master Income Trust is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales and currently employs 0 full-time employees. The company went IPO on 2017-10-09. Metrics Master Income Trust (the Fund) is an Australia-based investment fund. The Fund's investment objective is to provide monthly cash income, low risk of capital loss and portfolio diversification by actively managing diversified loan portfolios and participating in Australia's bank-dominated corporate loan market. The Manager seeks to implement active strategies designed to balance delivery of the Target Return, while seeking to preserve investor capital. The Fund seeks to deliver monthly cash income through a diversified portfolio of direct corporate loans with a focus on capital preservation. The investment manager of the fund is Metrics Credit Partners Pty Ltd.
π Performance (5Yr p.a)
0.45%
π Share price
$2.11 AUD
π° HIGH DIVIDEND
Want more shares? Try these...
Corazon Mining Ltd. is an exploration company, which engages in the exploration of nickel, cobalt, copper and gold. The company is headquartered in Perth, Western Australia. The company went IPO on 2005-06-30. The firm is an explorer advancing the Lynn Lake Nickel-Copper-Cobalt Sulfide Project in Manitoba, Canada, as well as the Mt Gilmore cobalt-copper-gold (Mt Gilmore) and Miriam nickel Sulfide projects (Miriam) in Australia. The Lynn Lake Nickel-Copper-Cobalt Sulfide Project is a significant Class-1 nickel resource. The Mt Gilmore Project is located 35 kilometers from the city of Grafton in north-eastern New South Wales. The firm owns an 80% interest in Mt Gilmore. Mt Gilmore is focused on multiple rare, cobalt-rich sulfide deposits, similar to Cobalt Ridge. The Miriam comprises five Prospecting License applications (P15/6135 to P15/6139 inclusive) and is located approximately 10 kilometers south-southwest of Coolgardie on an ultramafic trend, which hosts Auroch Mineralsβ Miriam and Nepean Nickel Deposits.
π Performance (5Yr p.a)
-2.05%
π Share price
$0.00 AUD
βοΈ MINING
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. The firm is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.
π Performance (5Yr p.a)
-15.83%
π Share price
$0.21 AUD
𧬠BIOTECHNOLOGY